Publisher
Springer International Publishing
Reference12 articles.
1. Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., Mankowski, J. L., Brown, A., Volsky, D. J., & McArthur, J. C. (2016). HIV-associated neurocognitive disorder—pathogenesis and prospects for treatment. Nature Reviews Neurology, 12(4), 234.
2. Eggers, C., Arendt, G., Hahn, K., Husstedt, I. W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., Straube, E., & German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI). (2017). HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. Journal of Neurology, 264(8), 1715–1727.
3. Cysique, L. A., & Brew, B. J. (2019). Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm. Journal of Neurovirology, 25(5), 710–721.
4. Konstantinopoulou, E., Ioannidis, P., Kiosseoglou, G., & Aretouli, E. (2021). Inhibitory control is associated with medication adherence in young HIV patients without comorbidities (pp. 1–9). Adult.
5. Siangphoe, U., & Archer, K. J. (2015). Gene expression in HIV-associated neurocognitive disorders: a meta-analysis. Journal of Acquired Immune Deficiency Syndromes (1999), 70(5), 479–488.